Abstract: Disclosed herein is a medical device. The medical device includes two coaxially aligned solenoids and a cannulated armature configured to be received within the two coaxially aligned solenoids.

Abstract: Disclosed herein is a medical device. The medical device includes two coaxially aligned solenoids and a cannulated armature configured to be received within the two coaxially aligned solenoids.

Abstract: Disclosed herein is a medical device. The medical device includes two coaxially aligned solenoids and a cannulated armature configured to be received within the two coaxially aligned solenoids.

Abstract: The invention in this application is a decision-support system that utilizes single system design (SSD) and a proprietary algorithm to determine real change is for each individual patient. It pinpoints right medication and dosage for an individual patient, targets standards for functionality, called Activities of Daily Living (ADLs), and Quality of Life Indicators (QoLIs) to maximize personal health and satisfaction. Further, the system has as hallmarks a specific communication system, provision of coordination of services and a continuum of care for seamless delivery of treatment targeted to the needs of an individual patient and his/her care network. It incorporates data collected from genomic testing, patient entry, and automated devices. It is a safety-enhancing, cost-saving, time-saving system that will address placebo effect. It will utilize a variety of technologies to gather data with flexibility for patient needs. It will utilize machine learning for added safety enhancement.

Abstract: A solventborne pigment dispersion having a volatile organic chemical (VOC) content that is less than 250 g/L for tinting solvent-based surface coatings is formulated using a vegetable oil-derived solvent component that is one or more methyl esters of vegetable oils, an acrylic resin containing at least 60% solids, one or more highly concentrated surfactants containing up to 100% by weight of active constituents and that contains no PMA or free aromatic moieties, and one or more organic pigments or one or more inorganic pigment, or a combination thereof.

Abstract: Described herein is a method for generating a full-scale template that allows for the precise positioning of audio and/or video (A/V) components, such as lighting, video and sound devices, onto an elongate structural member, such as a truss, in order to create a desired environment for a staged event.

Abstract: A system facilitates secure communication between an authorized user device and two or more servers via two or more channels that are associated with the respective servers. For each communication channel, the system receives a device identifier for the authorized user device and links the device identifiers together via another identifier, thereby allowing the system to recognize that the different device identifiers identify the same authorized user device. The system can identify an unauthorized device masquerading as the authorized user device by determining that a communication from the unauthorized device does not include another identifier linking the two or more device identifiers and/or by determining that a device identifier computed during the registration process is different from a linked identifier.

Abstract: The tissue ablation device includes a tissue ablation probe having an elongated probe shaft and electrodes carried by the distal end of the probe shaft. The device further comprises a cannula with a central lumen extending along a longitudinal axis for removably receiving the probe shaft. The cannula further comprises concentric inner and outer tubes extending along the longitudinal axis, wherein the outer is tube is translatable relative to the inner tube. The inner and outer tubes further comprise inner and outer apertures, respectively, that are aligned by translating the outer tube. When the inner and outer apertures are aligned, electrodes are deployed through the inner and outer apertures. One method includes introducing a cannula and a tissue ablation probe to a tissue site and operating the tissue ablation probe and the cannula to deploy the electrodes and ablate tissue.

Abstract: A solventborne pigment dispersion having a volatile organic chemical (VOC) content that is less than 250 g/L for tinting solvent-based surface coatings is formulated using a vegetable oil-derived solvent component that is one or more methyl esters of vegetable oils, an acrylic resin containing at least 60% solids, one or more highly concentrated surfactants containing up to 100% by weight of active constituents and that contains no PMA or free aromatic moieties, and one or more organic pigments or one or more inorganic pigment, or a combination thereof.

Abstract: The tissue ablation device includes a tissue ablation probe having an elongated probe shaft and electrodes carried by the distal end of the probe shaft. The device further comprises a cannula with a central lumen extending along a longitudinal axis for removably receiving the probe shaft. The cannula further comprises concentric inner and outer tubes extending along the longitudinal axis, wherein the outer is tube is translatable relative to the inner tube. The inner and outer tubes further comprise inner and outer apertures, respectively, that are aligned by translating the outer tube. When the inner and outer apertures are aligned, electrodes are deployed through the inner and outer apertures. One method includes introducing a cannula and a tissue ablation probe to a tissue site and operating the tissue ablation probe and the cannula to deploy the electrodes and ablate tissue.

Abstract: An interactive web site for use by a community of users includes multimedia information for education and use by the users. The multimedia information includes video information that demonstrates procedures of interest to the community. Tags are provided to the video identifying products and tools used in the video. Links are presented on the web site linking to additional information on the products and tools. Links are also provided that automatically schedule telephone conferences or other communications between the users and vendors of the products or services tagged in the videos.

Abstract: Disclosed are compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

Abstract: Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.

Abstract: Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.

Abstract: Disclosed are compounds of formula (I) Where Ar1, X, Y, Q, W, R3, R4, R5, R6 and Ry are defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. The compounds are also useful for treating diseases or conditions related to oncology and anticoagulant or fibrinolytic therapy. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

Abstract: Disclosed are compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

Abstract: Disclosed are compounds of formula (I) Where Ar1, X, R3, R4, R5 and R6 are defined herein. The compounds of the invention inhibit production of cytokines and are thus useful for treating cytokine mediated diseases. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.